The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInterserve Regulatory News (IRV)

  • There is currently no data for IRV

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Contract Win

24 Aug 2010 07:00

INTERSERVE APPOINTED TO £4.5bn PROCURE21+ NHS FRAMEWORK AGREEMENT

Interserve, the international services, maintenance and building group, has been named as one of the six Principal Supply Chain Partners (PCSPs) in the new ProCure21+ framework agreement, estimated to be worth up to £4.5 billion over its six-year term.

ProCure21+ will begin operating on 1st October 2010. It is a new framework that will replace the current ProCure21 programme through which Interserve has undertaken 136 schemes on behalf of 52 NHS Trusts since its pilot in 2002. Like ProCure21 the framework will streamline and improve the procurement process for NHS Trusts across England. This will enable them to select an appropriate supply chain partner to deliver acute, primary care and mental health facilities. As with ProCure21, there is a commitment to long-term relationships, collaborative working, integrated supply chains and the use of target-cost contracts.

There are a number of new features in ProCure21+ including:

* A centrally-provided risk evaluation tool for all schemes to improve

consistency and share approaches to managing common risks.

* A central repository of technical drawings and information that can be

re-used by all clients and supply-chain members under the "NHS Royalty-Free

Licence".

* An online "monthly monitoring" performance management system with a reduced

benchmarking data set to manage scheme performance centrally.

* Provision of a project start-up workshop by PCSPs on all schemes to align

stakeholder and supply chain requirements early in the process.

* Assurance of a VAT-compliant PSCP structure to maximise VAT recovery for

NHS Clients.

Commenting on Interserve's selection as a Principal Supply Chain Partner, Adrian Ringrose, Chief Executive, said, "The creation of ProCure21+ is excellent news. Under ProCure21 Interserve has been able to deliver many high-quality, value-for-money facilities and ProCure21+ will enable us to continue enhancing the health environment to meet the changing needs of the NHS. We are well positioned to do this as the only Health Framework Partner supporting the NHS across England, Scotland and Wales."

- Ends -

For further information please contact:

Amanda Cardall 0121 331 8125 Corporate Marketing Manager Elizabeth Morley / Tom Eckersley 020 7379 5151

Maitland About Interserve

Over the last five years Interserve has delivered healthcare projects with a total value of approximately £500 million, most of which has been through ProCure21.

Interserve's vision is to be the Trusted Partner of all our stakeholders. We are one of the world's foremost support services and construction companies, operating in the public and private sectors in the UK and internationally. We offer advice, design, construction and facilities management services for society's infrastructure and provide a range of plant and equipment in specialist fields. Interserve is based in the UK. It has revenue of £1.9 billion and a workforce of 50,000 people worldwide.

Health website: www.health.interserve.com

General website: www.interserve.com.

vendor
Date   Source Headline
11th Dec 20149:59 amRNSDirector/PDMR Shareholding
5th Dec 20147:00 amRNSInterserve acquires the Employment & Skills Group
28th Nov 20143:40 pmRNSDirector/PDMR Shareholding
18th Nov 201410:02 amRNSDirector/PDMR Shareholding
18th Nov 201410:00 amRNSDirector/PDMR Shareholding
17th Nov 20149:46 amRNSHummingbird Resources appoints Non-Exec Chairman
12th Nov 20147:00 amRNSInterim Management Statement
11th Nov 20142:20 pmRNSDirector/PDMR Shareholding
29th Oct 20141:45 pmRNSProbation and rehabilitation services contracts
27th Oct 20141:39 pmRNSDirector/PDMR Shareholding
20th Oct 20147:02 amRNSElementis appoints new Non-Executive Director
9th Oct 201410:15 amRNSDirector/PDMR Shareholding
30th Sep 201411:42 amRNSDirector/PDMR Shareholding
22nd Sep 20143:08 pmRNSHolding(s) in Company
15th Sep 20149:42 amRNSHolding(s) in Company
12th Sep 20141:55 pmRNSDirector/PDMR Shareholding
8th Sep 201410:30 amRNSDirector/PDMR Shareholding
2nd Sep 201411:05 amRNSDirector/PDMR Shareholding
27th Aug 20148:32 amRNSHolding(s) in Company
21st Aug 20149:50 amRNSPublication of the Half-Year Report 2014
21st Aug 20148:43 amRNSDirector/PDMR Shareholding - Correction
21st Aug 20147:00 amRNSInterserve-Shanks JV in £950m PPP contract
18th Aug 201410:55 amRNSDirector/PDMR Shareholding
15th Aug 20142:18 pmRNSDirector/PDMR Shareholding
6th Aug 20147:00 amRNSHalf-Year Results
31st Jul 20144:31 pmRNSRussell King Appointed Non-Exec Director of Sepura
24th Jul 20147:00 amRNSNotice of Results
9th Jul 20143:19 pmRNSDirector/PDMR Shareholding
9th Jul 20147:00 amRNSBoard Changes
9th Jul 20147:00 amRNSTrading Update
7th Jul 201412:21 pmRNSHolding(s) in Company
3rd Jul 201410:40 amRNSHolding(s) in Company
1st Jul 20148:43 amRNSBlocklisting Interim Review
27th Jun 20142:39 pmRNSHolding(s) in Company
24th Jun 20141:47 pmRNSTim Haywood appointed non-exec director at Tarsus
20th Jun 20147:00 amRNSUS$350m issue of US Private Placement loan notes
18th Jun 20143:29 pmRNSDirector/PDMR Shareholding
11th Jun 20148:17 amRNSDirector/PDMR Shareholding
29th May 20143:00 pmRNSHolding(s) in Company
27th May 201411:57 amRNSHolding(s) in Company
27th May 201411:00 amRNSDirector/PDMR Shareholding
22nd May 20143:07 pmRNSChange of Auditors
14th May 20142:20 pmRNSDirector/PDMR Shareholding
13th May 20142:44 pmRNSResult of AGM
13th May 20147:00 amRNSInterim Management Statement
12th May 20148:00 amRNSLandmarc wins new contract worth £322m
9th May 20141:56 pmRNSDirector/PDMR Shareholding
30th Apr 20142:16 pmRNSHolding(s) in Company
30th Apr 20148:48 amRNSTotal Voting Rights
25th Apr 20149:04 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.